Dramatic reductions in hepatic steatosis accompanied by improved HbA1c following a 4-week treatment of obese/diabetic/NAFLD patients with DD01, a novel long-acting GLP-1/glucagon r... von Bell, Adam, To, Dennis, Karanth, Subbu, Sosnovtseva, Svetlana, Lin, Yen-Huei, Shin, Jaehee

Volltext

LBP-05 - Dramatic reductions in hepatic steatosis accompanied by improved HbA1c following a 4-week treatment of obese/diabetic/NAFLD patients with DD01, a novel long-acting GLP-1/g... von Bell, Adam, To, Dennis, Karanth, Subbu, Sosnovtseva, Svetlana, Lin, Yen-Huei, Shin, Jaehee

Volltext

72-LB: DD01, a Novel Once-Weekly Dual GLP-1/Glucagon Receptor Agonist, Improves Metabolic Health and Achieves Rapid, Clinically Significant Reductions in Hepatic Steatosis followin... von TO, DENNIS, SHIN, JAEHEE, KARANTH, SUBBU, LIN, YEN-HUEI, SOSNOVTSEVA, SVETLANA, BELL, ADAM C.

Volltext

GLP-1R AGONISTS FOR USE IN A TREATMENT OF NEUROLOGIAL IMPAIRMENT ASSOCIATED WITH VIRAL INFECTION von Karanth, Subbu, Roschke, Viktor, Bell, Adam C, Lee, Seulki

Volltext bestellen

GLP-1R AGONISTS FOR USE IN A TREATMENT OF NEUROLOGICAL IMPAIRMENT ASSOCIATED WITH VIRAL INFECTION von BELL, Adam C, ROSCHKE, Viktor, KARANTH, Subbu, LEE, Seulki

Volltext bestellen